Weight-loss drug developers explore new GLP-1 medicines
UKPulse Health Desk
Pharmaceutical companies are reportedly working on a new generation of GLP-1 weight-loss drugs as some existing patents begin to expire.
- Pharma groups are seeking new GLP-1 medicines.
- Some patents for current GLP-1 weight-loss drugs are starting to expire.
Pharmaceutical companies are reportedly developing a new generation of GLP-1 weight-loss medicines. This comes as patents for some existing drugs in this category are beginning to expire.
The focus for these new medicines includes efforts to address potential side effects associated with current weight-loss drugs.